[Beta-blockers in glaucoma]

Abstract

The paper presents the main beta-blockers used in glaucoma therapy, the common international nomination and the commercial nominations of these therapeutical agents which have opened up new prospects in the medication of glaucoma. Some pharmacological properties of the beta-blockers are reviewed: the beta-adrenolytic strength, the pharmacodynamic properties, the pharmacokinetic effects, the action principle, the therapeutical effects and also the local and general side effects of the beta-blockers used in glaucoma therapy.